Tacrolimus Monohydrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 29 USDMF, 11 CEP/COS, 8 JDMF, 4 EU WC, 13 KDMF, 24 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

493 FDF Dossiers, 62 FDA Orange Book, 206 Europe, 19 Canada, 96 Australia, 32 South Africa, 78 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 0.75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 0.5MG BASE, CAPSULE;ORAL - EQ 1MG BASE, CAPSULE;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

2 SPI Pharma, 9 DKSH, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Capital Farma, 4 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 18 Controlled & Modified Release, 16 Direct Compression, 13 Granulation, 13 Lubricants & Glidants, 11 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 9 Empty Capsules, 9 Solubilizers, 9 Thickeners and Stabilizers, 8 Topical, 7 Co-Processed Excipients, 7 Emulsifying Agents, 5 Taste Masking, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Parenteral, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 55 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 137 Finished Drug Prices, 11 Annual Reports

MARKET PLACE

43 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

87 US Patents, 15 US Exclusivities, 19 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 USP, 1 JP, 10 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 206406 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TACROLIMUS(UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J)	TACROLIMUS ANHYDROUS	0.75mg \| 1mg \| 4mg

Inactive Ingredients

Ingredient Name	Carton Service, Incorporated
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
DIMETHICONE(92RU3N3Y1O)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
MAGNESIUM STEARATE(70097M6I30)
POLOXAMER 188(LQA7B6G8JG)
POLYETHYLENE GLYCOL 6000(30IQX730WE)
TARTARIC ACID(W4888I119H)

Drug Product Composition: Tacrolimus Monohydrate